Previcox

Verify with FDA CVM →

96 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
96
Total Reports
25
Deaths Reported
2600.0%
Death Rate

Active Ingredients

Previcox

Administration Routes

OralUnknownSubcutaneous

Species Affected

Dog 95
Horse 1

Most Affected Breeds

Retriever - Labrador 18
Retriever - Golden 10
Boxer (German Boxer) 10
Crossbred Canine/dog 6
Terrier - Bull - American Pit 4
Shepherd Dog - German 4
Spaniel (unspecified) 3
Terrier - Bull - Staffordshire 3
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 3
Collie - Border 2

Most Reported Reactions

Death 16
Ataxia 14
Seizure NOS 11
Lameness 10
Not eating 9
Falling 9
Anaemia NOS 9
Leucocytosis NOS 8
Limb weakness 8
Death by euthanasia 8
Vomiting 8
Lethargy (see also Central nervous system depression in Neurological) 8

Outcome Breakdown

Ongoing
55 (57.3%)
Died
17 (17.7%)
Outcome Unknown
10 (10.4%)
Euthanized
8 (8.3%)
Recovered/Normal
6 (6.3%)

Data Summary

Metric Value
Total adverse event reports 96
Reports involving death 25
Case-fatality rate (reported events) 2600.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Previcox Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 96 adverse event reports referencing Previcox, including 25 reports in which the animal died — a 2600.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Previcox. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Previcox reports are Dog (95 reports), Horse (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (18), Retriever - Golden (10), Boxer (German Boxer) (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Previcox are Death (16), Ataxia (14), Seizure NOS (11), Lameness (10). Of the 96 reports with a coded outcome, Ongoing is the leading category at 57.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Previcox.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial